These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2552374

  • 1. The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II.
    Glineur C, Bailly M, Ghysdael J.
    Oncogene; 1989 Oct; 4(10):1247-54. PubMed ID: 2552374
    [Abstract] [Full Text] [Related]

  • 2. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif.
    Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T.
    J Mol Biol; 1994 Feb 11; 236(1):16-25. PubMed ID: 8107101
    [Abstract] [Full Text] [Related]

  • 3. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein.
    Goldberg Y, Glineur C, Gesquière JC, Ricouart A, Sap J, Vennström B, Ghysdael J.
    EMBO J; 1988 Aug 11; 7(8):2425-33. PubMed ID: 2903825
    [Abstract] [Full Text] [Related]

  • 4. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
    Schroeder C, Gibson L, Beug H.
    Oncogene; 1992 Feb 11; 7(2):203-16. PubMed ID: 1347913
    [Abstract] [Full Text] [Related]

  • 5. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
    Rascle A, Ghysdael J, Samarut J.
    Oncogene; 1994 Oct 11; 9(10):2853-67. PubMed ID: 7916146
    [Abstract] [Full Text] [Related]

  • 6. The MYCN protein of human neuroblastoma cells is phosphorylated by casein kinase II in the central region and at serine 367.
    Hamann U, Wenzel A, Frank R, Schwab M.
    Oncogene; 1991 Oct 11; 6(10):1745-51. PubMed ID: 1923500
    [Abstract] [Full Text] [Related]

  • 7. Two nonmuscle myosin II heavy chain isoforms expressed in rabbit brains: filament forming properties, the effects of phosphorylation by protein kinase C and casein kinase II, and location of the phosphorylation sites.
    Murakami N, Chauhan VP, Elzinga M.
    Biochemistry; 1998 Feb 17; 37(7):1989-2003. PubMed ID: 9485326
    [Abstract] [Full Text] [Related]

  • 8. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
    Schroeder C, Gibson L, Zenke M, Beug H.
    Oncogene; 1992 Feb 17; 7(2):217-27. PubMed ID: 1347914
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies.
    Horowitz ZD, Yang CR, Forman BM, Casanova J, Samuels HH.
    Mol Endocrinol; 1989 Jan 17; 3(1):148-56. PubMed ID: 2464752
    [Abstract] [Full Text] [Related]

  • 10. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
    Bauer A, Mikulits W, Lagger G, Stengl G, Brosch G, Beug H.
    EMBO J; 1998 Aug 03; 17(15):4291-303. PubMed ID: 9687498
    [Abstract] [Full Text] [Related]

  • 11. A base mutation of the C-erbA beta thyroid hormone receptor in a kindred with generalized thyroid hormone resistance. Molecular heterogeneity in two other kindreds.
    Usala SJ, Tennyson GE, Bale AE, Lash RW, Gesundheit N, Wondisford FE, Accili D, Hauser P, Weintraub BD.
    J Clin Invest; 1990 Jan 03; 85(1):93-100. PubMed ID: 2153155
    [Abstract] [Full Text] [Related]

  • 12. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation.
    Lüscher B, Christenson E, Litchfield DW, Krebs EG, Eisenman RN.
    Nature; 1990 Apr 05; 344(6266):517-22. PubMed ID: 2157164
    [Abstract] [Full Text] [Related]

  • 13. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone.
    Hodin RA, Lazar MA, Chin WW.
    J Clin Invest; 1990 Jan 05; 85(1):101-5. PubMed ID: 2153150
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of thyroid hormone action by a non-hormone binding c-erbA protein generated by alternative mRNA splicing.
    Koenig RJ, Lazar MA, Hodin RA, Brent GA, Larsen PR, Chin WW, Moore DD.
    Nature; 1989 Feb 16; 337(6208):659-61. PubMed ID: 2537467
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
    Bauer A, Ulrich E, Andersson M, Beug H, von Lindern M.
    Oncogene; 1997 Aug 07; 15(6):701-15. PubMed ID: 9264411
    [Abstract] [Full Text] [Related]

  • 16. A single serine residue at position 375 of VP16 is critical for complex assembly with Oct-1 and HCF and is a target of phosphorylation by casein kinase II.
    O'Reilly D, Hanscombe O, O'Hare P.
    EMBO J; 1997 May 01; 16(9):2420-30. PubMed ID: 9171355
    [Abstract] [Full Text] [Related]

  • 17. Functional domains of the v-erbA protein necessary for oncogenesis are required for transcriptional activation in Saccharomyces cerevisiae.
    Smit-McBride Z, Privalsky ML.
    Oncogene; 1993 Jun 01; 8(6):1465-75. PubMed ID: 8099219
    [Abstract] [Full Text] [Related]

  • 18. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G, Gilmore TD.
    Oncogene; 1993 Mar 01; 8(3):721-30. PubMed ID: 8437855
    [Abstract] [Full Text] [Related]

  • 19. In vitro phosphorylation of caveolin-rich membrane domains: identification of an associated serine kinase activity as a casein kinase II-like enzyme.
    Sargiacomo M, Scherer PE, Tang ZL, Casanova JE, Lisanti MP.
    Oncogene; 1994 Sep 01; 9(9):2589-95. PubMed ID: 8058322
    [Abstract] [Full Text] [Related]

  • 20. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
    Wahlström GM, Harbers M, Vennström B.
    Oncogene; 1996 Aug 15; 13(4):843-52. PubMed ID: 8761306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.